Description: Enjoy an in-depth walkthrough of the facets of the lab testing world in this webcast. The agenda will include a discussion on genetic testing, which focuses on its general background, current trends and tests in the pipeline, as well as a focus on the approaches to achieve savings in lab testing. Finally, expect to check out sample actuarial analyses that will be used to identify areas of focus in lab management. Join us and take a deeper look into lab work in the actuarial health industry.

Description: This tool created graphs of Google's mobility Data. This version of the tool contains state-level U.S. data through July 31, 2020

Description: This tool created graphs of Google's mobility Data. This version of the tool contains global, country-level data through July 31, 2020

Description: In this webcast, presenters will outline the key content in ERM ASOPs 46, 47 and 55 and explore the impact each ASOP has on practitioners working in these fields. We will also describe the revision work currently under way in the ERM Committee of the Actuarial Standards Board.

Description: This project models and forecasts premature cardiovascular mortality, with a focus on two main risk factors - obesity status and education attainment level. It investigates the role of obesity and education in determining age-sex-specific premature cardiovascular mortality.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: 1997 Valuation Actuary Symposium, Session 5 explores health cash-flow testing.

Description: This session 99PD of the New Orleans Annual Meeting summary: Insurers today are looking for new ways to use currently available experience data to better predict future costs. Both the federal and state governments are looking at the possibility of using prescription drug data because it is more available and often of higher quality than other experience data. From the Record of the Society of Actuaries, Volume 27, No. 3, Session 99PD.

Description: This tool created graphs of Google's mobility Data. This version of the tool contains global, country-level data through July 31, 2020

Description: This is an Excel workbook that can be used as a tool for health insurance companies to model their potential risk exposure from an influenza pandemic. It is based on a model developed for a Society of Actuaries study examining the potential implications of a pandemic on the U.S. health insurance industry. The spreadsheet is saved with many of the same assumptions used in this research and reproduces the results of the exhibits contained in the June 2010 report, 'Potential Impact of Pandemic Influenza on the U.S. Health Insurance Industry.'